Skip to main content

Advertisement

SpringerLink
Log in

Management of malignant pleural effusion

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Malignant pleural effusion (MPE) often presents in patients with cancer at an advanced stage and thus carries a poor prognosis. This review updates the current knowledge on the management of MPE, focusing on recent literature about the efficacy and safety of the most common methods, including pleurodesis by either thoracoscopy with talc insufflation or thoracostomy with talc slurry, use of an indwelling pleural catheter, and intrapleural chemotherapy. Talc remains the agent of choice in pleurodesis, although the use of alternative agents continues to be explored. The choice of procedure to achieve pleurodesis depends on careful patient selection based on predictive factors and individual characteristics. Talc pleurodesis is relatively well tolerated and safe, as is an indwelling pleural catheter, in an appropriate patient population. Because MPE is a common problem in cancer patients, future research with more randomized, prospective designs and innovative interventions is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Antony VB, Loddenkemper R, Astoul P, et al.: Management of malignant pleural effusions. Am J Respir Crit Care Med 2000, 162:1987–2001.

    Google Scholar 

  2. Bethune N: Pleural poudrage. A new technique for the deliberate production of pleural adhesion as a preliminary to lobectomy. J Thorac Surg 1935, 4:251–261.

    Google Scholar 

  3. Tan C, Sedrakyan A, Browne J, et al.: The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006, 29:829–838.

    Article  PubMed  Google Scholar 

  4. Dresler CM, Olak J, Herndon JE, et al.: Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005, 127:909–915.

    Article  PubMed  Google Scholar 

  5. Marrazzo A, Noto A, Casa L, et al.: Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J Pain Symptom Manage 2005, 30:75–79.

    Article  PubMed  Google Scholar 

  6. Kolschmann S, Ballin A, Gillissen A: Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 2005, 128:1431–1435.

    Article  PubMed  Google Scholar 

  7. Stefani A, Natali P, Casali C, Morandi U: Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg 2006, 30:827–832.

    Article  PubMed  Google Scholar 

  8. Goodman A, Davies CW: Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 2006, 54:51–55.

    Article  PubMed  Google Scholar 

  9. Janssen JP, Collier G, Astoul P, et al.: Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007, 369:1535–1539.

    Article  PubMed  Google Scholar 

  10. Aelony Y: Talc pleurodesis and acute respiratory distress syndrome. Lancet 2007, 369:1494–1496.

    Article  PubMed  Google Scholar 

  11. Froudarakis ME, Klimathianaki M, Pougounias M: Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest 2006, 129:356–361.

    Article  PubMed  Google Scholar 

  12. Yildirim E, Dural K, Yazkan R, et al.: Rapid pleurodesis in symptomatic malignant pleural effusion. Eur J Cardiothorac Surg 2005, 27:19–22.

    Article  PubMed  Google Scholar 

  13. Akopov AL, Egorov VI, Varlamov VV, et al.: Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions. Eur J Cardiothorac Surg 2005, 28:750–753.

    Article  PubMed  Google Scholar 

  14. van den Toorn LM, Schaap E, Surmont VF, et al.: Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 2005, 50:123–127.

    Article  PubMed  Google Scholar 

  15. Tremblay A, Michaud G: Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006, 129:362–368.

    Article  PubMed  Google Scholar 

  16. Warren WH, Kim AW, Liptay MJ: Identification of clinical factors predicting PleurX catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg 2008, 33:89–94.

    Article  PubMed  Google Scholar 

  17. Jimenez CA, Mhatre AD, Martinez CH, et al.: Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest 2007, 132:1584–1590.

    Article  PubMed  Google Scholar 

  18. Janes SM, Rahman NM, Davies RJ, Lee YC: Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007, 131:1232–1234.

    Article  PubMed  Google Scholar 

  19. Seto T, Ushijima S, Yamamoto H, et al.: Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial. Br J Cancer 2006, 95:717–721.

    Article  PubMed  CAS  Google Scholar 

  20. Postmus PE, Brambilla E, Chansky K, et al.: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:686–693.

    Article  PubMed  Google Scholar 

  21. Goldstraw P, Crowley J, Chansky K, et al.: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:706–714.

    Article  PubMed  Google Scholar 

  22. Haas AR, Sterman DH, Musani AI: Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach. Chest 2007, 132:1036–1041.

    Article  PubMed  Google Scholar 

  23. Antevil JL, Putnam JB Jr: Tale pleurodesis for malignant effusions is preferred over the PleurX catheter (pro position). Ann Surg Oncol 2007, 14:2698–2699.

    PubMed  Google Scholar 

  24. Warren WH: Talc pleurodesis for malignant pleural effusions is preferred over the PleurX catheter (contrary position). Ann Surg Oncol 2007, 14:2700–2701.

    Article  PubMed  Google Scholar 

  25. Sterman DH, Recio A, Vachani A, et al.: Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res 2005, 11:7444–7453.

    Article  PubMed  CAS  Google Scholar 

  26. Sack U, Hoffmann M, Zhao XJ, et al.: Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 2005, 25:600–604.

    Article  PubMed  CAS  Google Scholar 

  27. Pichelmayer O, Gruenberger B, Zielinski C, Raderer M: Bevacizumab is active in malignant effusion. Ann Oncol 2006, 17:1853.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Bunting/Blaustein Cancer Research Building, 1650 Orleans Street, Baltimore, MD, 21231, USA

    Julie Brahmer

Authors
  1. Hongbin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Brahmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Brahmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, H., Brahmer, J. Management of malignant pleural effusion. Curr Oncol Rep 10, 287–293 (2008). https://doi.org/10.1007/s11912-008-0045-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-008-0045-4

Keywords

Search

Navigation